PT Dana Brata Luhur Tbk (IDX:TEBE)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions IDR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,529,150	803,125	1,002,300	1,092,250	841,675	681,050
Market Cap Growth	-8.92%	-19.87%	-8.24%	29.77%	23.59%	-71.12%
Enterprise Value	1,088,389	413,948	658,872	908,673	768,798	787,593
Last Close Price	1190.00	625.00	676.63	618.78	436.61	350.69
PE Ratio	14.12	6.03	4.55	3.36	5.12	-
PS Ratio	2.83	1.42	1.59	1.40	1.88	3.44
PB Ratio	1.40	0.74	0.92	1.04	1.03	1.04
P/TBV Ratio	1.41	0.74	0.93	1.04	1.04	1.05
P/FCF Ratio	11.92	5.23	4.80	3.65	3.05	10.63
P/OCF Ratio	11.09	4.92	4.67	2.66	2.99	10.28
EV/Sales Ratio	2.01	0.73	1.04	1.16	1.72	3.98
EV/EBITDA Ratio	5.85	1.90	1.91	1.93	2.96	11.69
EV/EBIT Ratio	8.66	2.62	2.31	2.17	3.69	69.71
EV/FCF Ratio	8.48	2.70	3.16	3.04	2.79	12.29
Debt / Equity Ratio	0	0	-	0.13	0.11	0.20
Debt / EBITDA Ratio	-	0.00	-	0.29	0.34	1.98
Debt / FCF Ratio	0	0	-	0.45	0.32	2.08
Asset Turnover	0.47	0.49	0.52	0.68	0.49	0.23
Inventory Turnover	38.84	35.35	36.94	52.85	46.58	19.68
Quick Ratio	11.64	9.32	9.17	1.90	2.40	1.00
Current Ratio	11.95	9.58	9.45	1.93	2.51	1.05
Return on Equity (ROE)	9.90%	12.32%	20.71%	35.10%	22.54%	-0.38%
Return on Assets (ROA)	6.77%	8.53%	14.54%	22.80%	14.29%	0.81%
Return on Capital (ROIC)	7.13%	9.05%	15.68%	25.00%	15.41%	0.87%
Return on Capital Employed (ROCE)	11.30%	14.20%	25.90%	39.20%	23.90%	1.50%
Earnings Yield	7.08%	16.58%	21.96%	29.80%	19.52%	-0.37%
FCF Yield	8.39%	19.13%	20.83%	27.40%	32.80%	9.41%
Dividend Yield	8.82%	-	15.52%	18.75%	-	1.43%
Payout Ratio	118.69%	96.48%	85.23%	27.64%	3.91%	-
Buyback Yield / Dilution	-	-	0.00%	-0.00%	-19.95%	16.63%
Total Shareholder Return	9.13%	-	15.52%	18.75%	-19.95%	18.06%

Updated Oct 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.